The global human insulin market value was USD 21.60 Billion in 2025, driven by the rising prevalence of diabetes across the globe. The global human insulin market share is anticipated to grow at a CAGR of 3.40% during the forecast period of 2026-2035 to achieve a value of USD 30.18 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
3.4%
Value in USD Billion
2026-2035
*this image is indicative*
The market for human insulin is expected to be driven by the growing demand from the North America region over the forecast period. This could be attributed to the rising incidence of diabetes and the increasing geriatric population, which are majorly contributing to the rising demand for human insulin in the region. On the basis of revenue, many countries in Europe like Germany, France, and Italy are predicted to contribute considerably to the growth of the human insulin industry over the forecast period. Meanwhile, the Asia Pacific region is expected to be a favourable market for human insulin over the forecast period. This could be ascribed to the growing research and development activities undertaken by various organisations and rising government initiatives in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Human insulin is referred to the synthetic insulin, which is grown in the laboratory and simulates the insulin in humans. The function of insulin is to regulate fat and carbohydrate metabolism in the body. It was developed through the 1960s and 1970s and finally approved for pharmaceutical use in 1982.
On the basis of product type, the market is divided into
Based on type, the industry can be segmented into
By brand, the industry is categorised into
On the basis of delivery service, the industry is segregated into
Based on applications, the industry is divided into
Based on distribution channel, the industry is divided into
The regional markets for the product include
The market for human insulin is driven by the rising cases of diabetes and obesity across the globe, which are the resultants of changing lifestyles and unhealthy consumption of sugar in various food and beverages. In addition, the rising investments in research and development activities by several organisations have led to an advanced and easier way of injecting insulin, which is also boosting the market growth of human insulin. Moreover, the introduction of the safety pen devices and pen needles for effective delivery of insulin is propelling the global market forward. Further, growing awareness of diabetes is expected to bolster the demand in the human insulin industry.
The report gives a detailed analysis of the following key players in the global human insulin market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Human insulin was valued at USD 21.60 Billion in 2025.
The market is expected to grow at a CAGR of 3.40% from 2026 to 2035 to reach a value of USD 30.18 Billion by 2035.
The industry is primarily being driven by the growing incidences of health issues such as obesity, changing consumer lifestyles, increased investments in research and development of advanced insulin injection mechanisms, and the availability of safety pen devices and pen needles for optimal insulin delivery.
The key trends boosting the market growth are the rising incidences of diabetes and the increasing geriatric population.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant product types include drugs and delivery device.
The major types of the product include insulin analogs and biosimilars, and delivery device.
The significant brands include NovoRapid/Novolog, Humalog, Insuman, Humulin, Lantus, Actrapid, Insulatard, and Mixtard, and others.
The different delivery devices include pens, syringes, pen needles, and others.
The major applications of the product include Type 1 and Type 2.
The major players in the industry are Novo Nordisk A/S, Biocon Limited, Sanofi S.A., Pfizer Inc., Eli Lilly and Company, and others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Type |
|
| Breakup by Brand |
|
| Breakup by Delivery Device |
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share